689
Views
22
CrossRef citations to date
0
Altmetric
Review

Therapy implications of the role of interleukin-2 in cancer

Pages 491-498 | Received 02 May 2016, Accepted 03 Oct 2016, Published online: 26 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhi-Feng Zhou, Feng Peng, Jie-Yu Li & Yun-Bin Ye. (2019) Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model. OncoTargets and Therapy 12, pages 7773-7784.
Read now
Zhuo Mao, Xuegang Fu, Zeyun Dong, Xiaodong Jian, Jian Sun & Jing Wei. (2018) Study of the molecular mechanism of interleukin-2 mutein D10 binding to IL-2 receptors by molecular simulations. Molecular Simulation 44:12, pages 973-980.
Read now

Articles from other publishers (20)

Feng Tang, Feng-Ping Li, Xue-Tao Huang, Guo-Hua Wang, Ze-Fen Wang & Zhi-Qiang Li. (2023) Anti-Vascular Endothelial Growth Factor Therapy Abolishes Glioma-Associated Endothelial Cell-Induced Tumor Invasion. Journal of Molecular Neuroscience 73:2-3, pages 104-116.
Crossref
Melisa Intan Barliana, Ajeng Diantini, Anas Subarnas & Rizky Abdulah. (2022) Kaempferol-3-O-Rhamnoside Inhibits the Proliferation of Jurkat Cells Through Jun Amino-Terminal Kinase Signaling. The Natural Products Journal 12:4.
Crossref
Godfrey Chi-Fung Chan & Carol Matias Chan. (2022) Anti-GD2 Directed Immunotherapy for High-Risk and Metastatic Neuroblastoma. Biomolecules 12:3, pages 358.
Crossref
Yue Sun, Jiayu Yang, Tong Yang, Yifan Li, Rongyue Zhu, Yanhui Hou & Yanhua Liu. (2021) Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation. Acta Biomaterialia 128, pages 447-461.
Crossref
Anahita Mohseni & Afsoon Shariat. (2021) Evaluation of in vitro Effect of Pyocyanine Pigment on Interleukin-2 Secretion from Peripheral Blood Mononuclear Cells in Cancer Patients. Iranian Journal of Medical Microbiology 15:3, pages 327-344.
Crossref
Juan Pablo Ortiz-Aguirre, Esteban Alejandro Velandia-Vargas, Oscar Mauricio Rodríguez-Bohorquez, Diego Amaya-Ramírez, David Bernal-Estévez & Carlos Alberto Parra-López. (2021) Inmunoterapia personalizada contra el cáncer basada en neoantígenos. Revisión de la literatura. Revista de la Facultad de Medicina 69:3, pages e81633.
Crossref
Daria S. Chulpanova, Zarema E. Gilazieva, Sevindzh K. Kletukhina, Aleksandr M. Aimaletdinov, Ekaterina E. Garanina, Victoria James, Albert A. Rizvanov & Valeriya V. Solovyeva. (2021) Cytochalasin B-Induced Membrane Vesicles from Human Mesenchymal Stem Cells Overexpressing IL2 Are Able to Stimulate CD8+ T-Killers to Kill Human Triple Negative Breast Cancer Cells. Biology 10:2, pages 141.
Crossref
Qi Zeng, Yun Zeng, Xu Nie, Yingying Guo & Yonghua Zhan. (2020) Britanin Exhibits Potential Inhibitory Activity on Human Prostate Cancer Cell Lines Through PI3K/Akt/NF-κB Signaling Pathways. Planta Medica 86:18, pages 1401-1410.
Crossref
Gennady M. Zharinov, Oleg A. Bogomolov, Irina V. Chepurnaya, Natalia Yu. Neklasova & Vladimir N. Anisimov. (2020) Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment. Oncotarget 11:41, pages 3723-3729.
Crossref
Jia-Qi He, Min-Xia Zheng, Hua-Zhong Ying, Yu-Sen Zhong, Huan-Huan Zhang, Min Xu & Chen-Huan Yu. (2020) PRP1, a heteropolysaccharide from Platycodonis Radix, induced apoptosis of HepG2 cells via regulating miR-21-mediated PI3K/AKT pathway. International Journal of Biological Macromolecules 158, pages 542-551.
Crossref
Parham Jabbarzadeh Kaboli, Lingling Zhang, Shixin Xiang, Jing Shen, Mingxing Li, Yueshui Zhao, Xu Wu, Qijie Zhao, Hanyu Zhang, Ling Lin, Jianhua Yin, Yuanlin Wu, Lin Wan, Tao Yi, Xiang Li, Chi Hin Cho, Jing Li, Zhangang Xiao & Qinglian Wen. (2020) Molecular Markers of Regulatory T Cells in Cancer Immunotherapy with Special Focus on Acute Myeloid Leukemia (AML) - A Systematic Review. Current Medicinal Chemistry 27:28, pages 4673-4698.
Crossref
Daria S. Chulpanova, Valeriya V. Solovyeva, Victoria James, Svetlana S. Arkhipova, Marina O. Gomzikova, Ekaterina E. Garanina, Elvira R. Akhmetzyanova, Leysan G. Tazetdinova, Svetlana F. Khaiboullina & Albert A. Rizvanov. (2020) Human Mesenchymal Stem Cells Overexpressing Interleukin 2 Can Suppress Proliferation of Neuroblastoma Cells in Co-Culture and Activate Mononuclear Cells In Vitro. Bioengineering 7:2, pages 59.
Crossref
Martha Baydoun, Olivier Moralès, Céline Frochot, Colombeau Ludovic, Bertrand Leroux, Elise Thecua, Laurine Ziane, Anne Grabarz, Abhishek Kumar, Clémentine de Schutter, Pierre Collinet, Henri Azais, Serge Mordon & Nadira Delhem. (2020) Photodynamic Therapy Using a New Folate Receptor-Targeted Photosensitizer on Peritoneal Ovarian Cancer Cells Induces the Release of Extracellular Vesicles with Immunoactivating Properties. Journal of Clinical Medicine 9:4, pages 1185.
Crossref
Paolo Lissoni, Giusy Messina & Giuseppe di Fede. (2020) A Short-Period Therapy with Subcutaneous Low-Dose IL-2 Plus High-Dose Melatonin to Correct Advanced Cancer-Related Lymphocytopenia: Possible Impact on the Survival Time. Psychoneuroimmunology Journal 1, pages 1-4.
Crossref
Alessandra Lopes, Sara Feola, Sophie Ligot, Manlio Fusciello, Gaëlle Vandermeulen, Véronique Préat & Vincenzo Cerullo. (2019) Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Lisa Richter, Sonja Kropp, Peter Proksch & Stefanie Scheu. (2019) A mouse model-based screening platform for the identification of immune activating compounds such as natural products for novel cancer immunotherapies. Bioorganic & Medicinal Chemistry 27:23, pages 115145.
Crossref
Hirohito Abo, Kyle L. Flannigan, Duke Geem, Vu L. Ngo, Akihito Harusato & Timothy L. Denning. (2019) Combined IL-2 Immunocomplex and Anti-IL-5 mAb Treatment Expands Foxp3+ Treg Cells in the Absence of Eosinophilia and Ameliorates Experimental Colitis. Frontiers in Immunology 10.
Crossref
Clara Di Vito, Joanna Mikulak, Elisa Zaghi, Silvia Pesce, Emanuela Marcenaro & Domenico Mavilio. (2019) NK cells to cure cancer. Seminars in Immunology 41, pages 101272.
Crossref
Ruth Ladenstein, Ulrike Pötschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Isaac Yaniv, Genevieve Laureys, Penelope Brock, Jean Marie Michon, Cormac Owens, Toby Trahair, Godfrey Chi Fung Chan, Ellen Ruud, Henrik Schroeder, Maja Beck Popovic, Guenter Schreier, Hans Loibner, Peter Ambros, Keith Holmes, Maria Rita Castellani, Mark N Gaze, Alberto Garaventa, Andrew D J Pearson & Holger N Lode. (2018) Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial. The Lancet Oncology 19:12, pages 1617-1629.
Crossref
Giandomenico Roviello, Laura Zanotti, Pierpaolo Correale, Angela Gobbi, Simon Wigfield, Alessandra Guglielmi, Chiara Pacifico & Daniele Generali. (2017) Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?. Immunotherapy 9:1, pages 25-32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.